{"database":"EGA","file_versions":[],"scores":null,"additional":{"omics_type":["Genomics"],"dataset_type":["Illumina HiSeq 2500;ILLUMINA"],"full_dataset_link":["https://ega-archive.org/datasets/EGAD00001003441"],"sample_count":["584"],"description":["EGA dataset EGAD00001003441"],"repository":["EGA"],"title":["Exome and Transcriptome for pan-cancer gene-drug analysis"],"name_synonyms":["Vasp, VASP, Data Set., DmelCG15112, ENHANCER OF ATNSI ACTIVITY, MENA, NDPP1, l(2)02029, Enb, enb, ENA, Ena, CG15112, ENA/VASP"],"description_synonyms":["whole exome, primary cancer, Transcriptome, Malignant Neoplasm, Malignancy, Transcriptome Profile, Neoplasms, Profile, Expression Profiles, Benign Neoplasm, Exomes, Gene Expression Profile, Benign Neoplasms, Gene, patient, Cancers, Profiles, Tumor, Malignant, Client, malignant tumor, Signatures, Cell, Malignant Neoplasms, Neoplasias, Gene Expression, Benign, MT, Patient, malignant neoplasm, Expression Signature, Gene Expression Profiles, Transcriptome Profiles., Clients, Expression Signatures, Gene Expression Signatures, Neoplasm, Transcriptomes, Malignancies, Gene Expression Signature, Signature, other neoplasm, Expression Profile, Neoplasia, Cancer, Tumors"],"additional_accession":[]},"is_claimable":false,"name":"ena-DATASET-IRCR-11-07-2017-02:57:13:607-145 - samples","description":"Total of 584 tumor specimens and/or patient-derived cells across 14 cancer types were subjected for whole-exome/targeted-exome and/or whole-transcriptome sequencing.","dates":{"updated":"2018-06-11 11:51:02"},"accession":"EGAD00001003441","cross_references":{"TAXONOMY":["9606"],"EGA":["EGAC00001000272","EGAS00001002515"]}}